237 related articles for article (PubMed ID: 19288457)
1. Performance of first-trimester combined screening for trisomy 13 and 18 with the double test taken at a gestational age of 8 + 0 to 13 + 6.
Kirkegaard I; Petersen OB; Uldbjerg N; Tørring N
Prenat Diagn; 2009 Jun; 29(6):582-7. PubMed ID: 19288457
[TBL] [Abstract][Full Text] [Related]
2. Improved performance of first-trimester combined screening for trisomy 21 with the double test taken before a gestational age of 10 weeks.
Kirkegaard I; Petersen OB; Uldbjerg N; Tørring N
Prenat Diagn; 2008 Sep; 28(9):839-44. PubMed ID: 18677711
[TBL] [Abstract][Full Text] [Related]
3. Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A.
Kagan KO; Wright D; Valencia C; Maiz N; Nicolaides KH
Hum Reprod; 2008 Sep; 23(9):1968-75. PubMed ID: 18544579
[TBL] [Abstract][Full Text] [Related]
4. [The prenatal detection of trisomy 13, 18, and 21: comparison of the advanced first trimester screening (AFS) with the first trimester screening according to Nicolaides].
Hörmansdörfer C; Schmidt P; Hillemanns P; Scharf A
Z Geburtshilfe Neonatol; 2007 Dec; 211(6):243-9. PubMed ID: 18176905
[TBL] [Abstract][Full Text] [Related]
5. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
[TBL] [Abstract][Full Text] [Related]
6. Screening for triploidy by the risk algorithms for trisomies 21, 18 and 13 at 11 weeks to 13 weeks and 6 days of gestation.
Kagan KO; Anderson JM; Anwandter G; Neksasova K; Nicolaides KH
Prenat Diagn; 2008 Dec; 28(13):1209-13. PubMed ID: 19039823
[TBL] [Abstract][Full Text] [Related]
7. First-trimester screening for trisomy 21 in Denmark: implications for detection and birth rates of trisomy 18 and trisomy 13.
Ekelund CK; Petersen OB; Skibsted L; Kjaergaard S; Vogel I; Tabor A;
Ultrasound Obstet Gynecol; 2011 Aug; 38(2):140-4. PubMed ID: 21229566
[TBL] [Abstract][Full Text] [Related]
8. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
[TBL] [Abstract][Full Text] [Related]
9. Effect of maternal smoking on prenatal screening for Down syndrome and trisomy 18 in the first trimester of pregnancy.
Miron P; Côté YP; Lambert J
Prenat Diagn; 2008 Mar; 28(3):180-5. PubMed ID: 18264956
[TBL] [Abstract][Full Text] [Related]
10. Comparison of serum markers in first-trimester down syndrome screening.
Canick JA; Lambert-Messerlian GM; Palomaki GE; Neveux LM; Malone FD; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Saade GR; Berkowitz RL; Dar P; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
Obstet Gynecol; 2006 Nov; 108(5):1192-9. PubMed ID: 17077242
[TBL] [Abstract][Full Text] [Related]
11. Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening?
Comstock CH; Malone FD; Ball RH; Nyberg DA; Saade GR; Berkowitz RL; Ferreira J; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Bianchi DW; D'Alton ME;
Am J Obstet Gynecol; 2006 Sep; 195(3):843-7. PubMed ID: 16949423
[TBL] [Abstract][Full Text] [Related]
12. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
[TBL] [Abstract][Full Text] [Related]
13. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics.
Kagan KO; Wright D; Spencer K; Molina FS; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 May; 31(5):493-502. PubMed ID: 18432600
[TBL] [Abstract][Full Text] [Related]
14. Clinical first-trimester routine screening for Down syndrome in singleton pregnancies in northern Finland.
Valinen Y; Rapakko K; Kokkonen H; Laitinen P; Tekay A; Ahola T; Ryynanen M
Am J Obstet Gynecol; 2007 Mar; 196(3):278.e1-5. PubMed ID: 17346554
[TBL] [Abstract][Full Text] [Related]
15. First-trimester screening for trisomy 21 in twin pregnancy: does the addition of biochemistry make an improvement?
Goncé A; Borrell A; Fortuny A; Casals E; Martínez MA; Mercadé I; Cararach V; Vanrell JA
Prenat Diagn; 2005 Dec; 25(12):1156-61. PubMed ID: 16231401
[TBL] [Abstract][Full Text] [Related]
16. First trimester predictors of adverse pregnancy outcomes.
Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
[TBL] [Abstract][Full Text] [Related]
17. First-trimester Down syndrome screening performance in the Dutch population; how to achieve further improvement?
Wortelboer EJ; Koster MP; Stoutenbeek P; Elvers LH; Loeber JG; Visser GH; Schielen PC
Prenat Diagn; 2009 Jun; 29(6):588-92. PubMed ID: 19294632
[TBL] [Abstract][Full Text] [Related]
18. First-trimester combined screening for Down syndrome: prediction of low birth weight, small for gestational age and pre-term delivery in a cohort of non-selected women.
Pihl K; Sørensen TL; Nørgaard-Pedersen B; Larsen SO; Nguyen TH; Krebs L; Larsen T; Christiansen M
Prenat Diagn; 2008 Mar; 28(3):247-53. PubMed ID: 18302310
[TBL] [Abstract][Full Text] [Related]
19. Multi-centre first-trimester screening for Down syndrome in the Netherlands in routine clinical practice.
Schielen PC; van Leeuwen-Spruijt M; Belmouden I; Elvers LH; Jonker M; Loeber JG
Prenat Diagn; 2006 Aug; 26(8):711-8. PubMed ID: 16752435
[TBL] [Abstract][Full Text] [Related]
20. First trimester Down's syndrome screening marker values and cigarette smoking: new data and a meta-analysis on free beta human chorionic gonadotophin, pregnancy-associated plasma protein-A and nuchal translucency.
Bestwick JP; Huttly WJ; Wald NJ
J Med Screen; 2008; 15(4):204-6. PubMed ID: 19106261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
